Our Technology

Portable retinal imager examines retinal microvasculature

We are developing a low-cost, easy-to-use, portable retinal imager designed to non-invasively capture physiological information from the retinal microvasculature, providing a quantitative means of monitoring the progression of various metrics indicative of ophthalmic and systemic disease. Our approach eliminates the need for pupil dilation or contrast dyes and allows for important eye exams to be performed in primary care and community care environments. By positioning our devices in primary care centers, healthcare facilities, pharmacies, and community clinics worldwide, we hope to increase access to high-quality, essential care for millions of at-risk and underserved individuals while reducing the cost of care associated with eye exams.


Initial Focus

Millions of people in the world suffer from diabetes.

Nearly 29 million Americans (9% of the population) have diabetes, with an additional 7 million undiagnosed and 79 million at risk. Globally, more than 371 million people currently suffer from diabetes, a population that is expected to grow to well over 550 million by 2030.

World Diabetes Statistics

Approximately 1 in 3 diabetics currently suffer from diabetic retinopathy

DR is a medical condition that results from prolonged mismanagement of diabetes which manifests as damage to the small blood vessels (or micro-vasculature) of the retina, and is the most frequent cause of blindness among adults. Each year, nearly 65,000 Americans progress to the late stages of the condition and as many as 25,000 lose their eyesight. Through early detection, however, healthcare providers can better manage a patient’s diabetes, preventing the vascular damage that occurs as DR progresses.

  • Diabetics receiving recommended annual eye exam 50%
  • Diabetics who have never had an eye exam 36%
The primary reasons cited for the failure to obtain an annual eye exam are:

  • inconvenience
  • cost
  • lack of symptoms

Prevention of vision loss associated with diabetes is an area of significant need that may benefit from the use of our technology.

Recent News

Stay connected as we continue to grow!

Columbia medical device company Vasoptic Medical moves to city

Medical-device startup Vasoptic Medical Inc. is moving its headquarters to Baltimore’s Locust Point neighborhood as the company continues to move its eye imaging technology closer to market. Vasoptic is relocating from a 900-square-foot office in Columbia to a 2,200-square-foot office in the old Philips building at 1215 E. Fort Ave. in Locust Point. The move is made possible in part by a $250,000 investment from the Abell Foundation. For full story click... read more

Vasoptic Medical gets $250K investment from Abell Foundation

Bye bye, ‘burbs. Vasoptic Medical is officially a city company now. The medical device startup, which is making a device that allows primary-care doctors to give diabetes patients eye exams rather than making an extra trip to the eye doctor, completed its move from Columbia to Locust Point. The company’s new office is within Mindgrub’s climbing-wall-outfitted space near McHenry Row. Earlier this summer, Vasoptic CEO M. Jason Brooke told us the move would help the company be closer to Johns Hopkins University and the University of Maryland School of Medicine, where the company is testing the device. He also believes the location will help in recruiting since it is close to other tech companies, amenities and interstate access. And let’s be honest: Mindgrub has a climbing wall. For full story click here.... read more

Vasoptic Medical Receives Abell Foundation Investment and Moves Headquarters to Baltimore

FOR IMMEDIATE RELEASE Baltimore, MD (August 6, 2015)—Vasoptic Medical, Inc., a Maryland-based medical device company, announced today that they have received investment from the Abell Foundation to support the development of Vasoptic’s vascular imaging technology. In conjunction with the investment, the company has moved its headquarters to the McHenry Row area of Locust Point in Baltimore. “We are honored and proud to be among a growing number of medical technology companies in the Abell Foundation investment portfolio,” said M. Jason Brooke, CEO of Vasoptic Medical. “Baltimore is rapidly becoming an innovation hub for the medical device industry. We are excited to locate and grow our company in such a rich, entrepreneurial ecosystem. Abell’s investment will enable us to bring important eye care to the people of Baltimore and beyond.” “As a highly innovative company focused on improving the quality of accessible healthcare, Vasoptic is a great example of the type of company we want to see locate in Baltimore,” said Robert C. Embry, Jr., President, the Abell Foundation. “The company is poised to significantly increase access to affordable, quality eye care and will contribute to the growth of Baltimore’s thriving tech industry.” The company’s technology will be used for the rapid and inexpensive assessment of the functional state of the retina, which can lead to timely detection of information pertaining to health and disease conditions. Vasoptic’s initial focus is on enabling primary care providers and healthcare retailers to perform routine eye exams in their diabetic patient population for early detection of diabetic retinopathy. Diabetic retinopathy is a condition that affects nearly 1 in 3 diabetic patients and, if unmanaged,... read more

Join our Effort

As an energetic and devoted team of engineers, scientists, clinicians, technologists, and—most importantly—patients, we at Team Vasoptic are passionate about using innovative technologies to increase access to high-quality care at reduced costs. We are eager to grow the Team through strategic partnerships, research collaborations, and other relationships that embrace a vision of better healthcare through technological innovation. If you would like to be a part of our effort or just want to learn more about what we’re doing, please contact us!

Current Openings

Vasoptic Medical is looking for bright, motivated individuals to join our team. We are committed to producing quality work to support our mission of advancing healthcare through innovative diagnostics. If you think you have what it takes to be part of the Vasoptic team, we look forward to hearing from you!

Electronics Engineer

This position involves the development of various aspects of the electronic systems associated with Vasoptic’s product portfolio, which includes circuit design and implementation, integration of various modules and sub-systems, and implementation of programmable logic controllers. Candidates should be highly motivated, creative, self-driven, team-oriented, problem solvers who can achieve technical objectives and assignments without significant supervision.

View full job description.

Research Scientist

This position involves the design, development, implementation, and evaluation of innovative medical imaging technologies, including hardware and software components and subsystems. Candidates should be highly motivated, creative, self-driven, team-oriented, problem solvers who can achieve technical objectives and assignments without significant supervision.

View full job description.

Vasoptic Medical, Inc.
1215 East Fort Avenue
Suite 203
Baltimore, MD 21230
United States of America
Phone +1 (443) 961-3591

  • This field is for validation purposes and should be left unchanged.